Heaseong Park.jpg

Haeseong Park, MD, MPH

Assistant Professor
Department of Medicine
Oncology Division
Molecular Oncology

Clinical Interests

  • Breast cancer
  • Gastrointestinal cancer

Research Interests

  • Phase 1 clinical trials
  • Cancer immunotherapy
  • Molecular targeted therapy


  • 314-454-5102 (tel)
  • 314-362-7086 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8056
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Peer-reviewed Publications

  • Pacritinib to Inhibit JAK/STAT Signaling in Refractory Metastatic Colon and Rectal Cancer
    Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC
    J Gastrointest Oncol 2017 Dec;8(6):985-989
  • Progress in PD-1-Based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers
    Park H, Chen B, Ciorba MA
    Gastroenterology 2017 Oct;153(4):1162-1163
  • Phase I Dose-Escalation Study of the mTOR Inhibitor Sirolimus and the HDAC Inhibitor Vorinostat in Patients With Advanced Malignancy
    Park H, Garrido-Laguna I, Naing A, Fu S, Falchook GS, Piha-Paul SA, Wheler JJ, Hong DS, Tsimberidou AM, Subbiah V, Zinner RG, Kaseb AO, Patel S, Fanale MA, Velez-Bravo VM, Meric-Bernstam F, Kurzrock R, Janku F
    Oncotarget 2016 Oct 11;7(41):67521-67531
  • Synergism Between Bosutinib (SKI-606) and the Chk1 Inhibitor (PF-00477736) in Highly Imatinib-Resistant BCR/ABL(+) Leukemia Cells
    Nguyen T, Hawkins E, Kolluri A, Kmieciak M, Park H, Lin H, Grant S
    Leuk Res 2015 Jan;39(1):65-71
  • North Central Cancer Treatment Group N10C2 (Alliance): A Double-Blind Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes
    Park H, Qin R, Smith TJ, Atherton PJ, Barton DL, Sturtz K, Dakhil SR, Anderson DM, Flynn K, Puttabasavaiah S, Le-Lindqwister NA, Padula GD, Loprinzi CL
    Menopause 2015 Jun;22(6):627-32
  • Disseminated Histoplasmosis in Peripheral Blood Smear
    Park H, Shafer D
    Blood 2014 Mar 6;123(10):1445
  • Strategies to Circumvent the T315I Gatekeeper Mutation in the Bcr-Abl Tyrosine Kinase
    Bose P, Park H, Al-Khafaji J, Grant S
    Leuk Res Rep 2013 Jan 1;2(1):18-20
  • Acute Changes in N-Terminal Pro-B-Type Natriuretic Peptide During Hospitalization and Risk of Readmission and Mortality in Patients With Heart Failure
    Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, Brotman DJ
    Am J Cardiol 2011 Apr 15;107(8):1191-5
  • A Pilot Phase II Trial of Magnesium Supplements to Reduce Menopausal Hot Flashes in Breast Cancer Patients
    Park H, Parker GL, Boardman CH, Morris MM, Smith TJ
    Support Care Cancer 2011 Jun;19(6):859-63
  • Usefulness of Cystatin C and Prognosis Following Admission for Acute Heart Failure
    Campbell CY, Clarke W, Park H, Haq N, Barone BB, Brotman DJ
    Am J Cardiol 2009 Aug 1;104(3):389-92
  • A Systematic Review of Barriers and Interventions to Improve Appropriate Use of Therapies for Sickle Cell Disease
    Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB
    J Natl Med Assoc 2009 Oct;101(10):1022-33
  • Hydroxyurea for the Treatment of Sickle Cell Disease
    Segal JB, Strouse JJ, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S
    Evid Rep Technol Assess (Full Rep) 2008 Mar;(165):1-95
  • Systematic Review: Hydroxyurea for the Treatment of Adults With Sickle Cell Disease
    Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB
    Ann Intern Med 2008 Jun 17;148(12):939-55